Search - tctmd.com

Displaying 821 - 840 of 1111

Sort: Relevancy | Date

Presentation

Optimal Duration Of Dual Antiplatelet Therapy After DES Implantation

Presenter: C.W. Lee

October 10, 2013

News Daily News

Failure to Give Pre-PCI Aspirin Not Infrequent Cause of Complications

Caitlin E. Cox

October 04, 2013

News Daily News

Triple Antiplatelet Therapy May be Better for Longer Stent Lengths

Jason Kahn

September 27, 2013

News Daily News

Prior Cancer Diagnosis Increases Mortality Risk After Primary PCI for STEMI

L.A. McKeown

September 27, 2013

News Daily News

La Terapia Antiplaquetaria Triple podría ser Mejor para Longitudes de Stent Más Largas

Jason Kahn

September 27, 2013

Presentation

Comparison of Dual vs. Triple Antiplatelet Therapy After DES According to Stent Length

Presenter: S-W Lee

September 26, 2013

News Daily News

DESSOLVE I: Bioabsorbable Polymer SES Shows Promise in De Novo Lesions

Yael L. Maxwell

September 20, 2013

News Daily News

Cilostazol as Safe as Double-Dose Clopidogrel in Patients Undergoing PCI with DES

Yael L. Maxwell

September 20, 2013

Presentation ESC 2013

Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI):Results from the Real-World PARIS Registry

Presenter: 32040|Roxana Mehran

September 01, 2013

News Conference News ESC 2013

Length of DAPT, Reasons for Discontinuation Have Disparate Effects

Yael L. Maxwell

September 01, 2013

News Daily News

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

August 30, 2013

News Daily News

Oral Sirolimus Appears to Augment Efficacy of BMS

Caitlin E. Cox

August 23, 2013

News Daily News

Meta-analysis: DES More Effective Than BMS for STEMI with No Safety Trade-off

L.A. McKeown

August 19, 2013

News Daily News

Contemporary ZES Perform Well in Treating In-Stent Restenosis

August 14, 2013

News Daily News

No Increased Mortality Risk for DES Patients with High Platelet Reactivity on Clopidogrel

L.A. McKeown

August 12, 2013

News Daily News

Performance of Bioabsorbable Scaffold Can Be Tracked with Noninvasive CT

August 08, 2013

News Daily News

Add-on Cilostazol Reduces Restenosis in High-Risk Patients Receiving DES

August 08, 2013

News Daily News

Staged Stenting Best for Patients with Carotid Disease Prior to Heart Surgery

Caitlin E. Cox

August 05, 2013

News Daily News

In Older ACS Patients, Half-Dose Prasugrel as Safe as Clopidogrel But No More Effective

July 25, 2013

News Daily News

En Pacientes Ancianos, Media Dosis de Prasugrel es igual de Segura que el Clopidogrel aunque No Más Eficaz

July 25, 2013

Advertisement

Optimal Duration Of Dual Antiplatelet Therapy After DES Implantation

Failure to Give Pre-PCI Aspirin Not Infrequent Cause of Complications

Triple Antiplatelet Therapy May be Better for Longer Stent Lengths

Prior Cancer Diagnosis Increases Mortality Risk After Primary PCI for STEMI

La Terapia Antiplaquetaria Triple podría ser Mejor para Longitudes de Stent Más Largas

Comparison of Dual vs. Triple Antiplatelet Therapy After DES According to Stent Length

DESSOLVE I: Bioabsorbable Polymer SES Shows Promise in De Novo Lesions

Cilostazol as Safe as Double-Dose Clopidogrel in Patients Undergoing PCI with DES

Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI):Results from the Real-World PARIS Registry

Length of DAPT, Reasons for Discontinuation Have Disparate Effects

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

Oral Sirolimus Appears to Augment Efficacy of BMS

Meta-analysis: DES More Effective Than BMS for STEMI with No Safety Trade-off

Contemporary ZES Perform Well in Treating In-Stent Restenosis

No Increased Mortality Risk for DES Patients with High Platelet Reactivity on Clopidogrel

Performance of Bioabsorbable Scaffold Can Be Tracked with Noninvasive CT

Add-on Cilostazol Reduces Restenosis in High-Risk Patients Receiving DES

Staged Stenting Best for Patients with Carotid Disease Prior to Heart Surgery

In Older ACS Patients, Half-Dose Prasugrel as Safe as Clopidogrel But No More Effective

En Pacientes Ancianos, Media Dosis de Prasugrel es igual de Segura que el Clopidogrel aunque No Más Eficaz

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content